| 7595403 |
Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
Patrick Irving Eacho, Patricia Sue Foxworthy-Mason, Jose Eduardo Lopez, Marian Mosior, Michael Enrico Richett |
2009-09-29 |
$67,969,000 |
| 7547691 |
[4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases |
Karl Robert Dahnke, Michael Enrico Richett, Chuan Shih, Q May Wang, Bo Zhang |
2009-06-16 |
$288,181,000 |
| 7449477 |
7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) |
David Anthony Barda, Kenneth J. Henry, Jianping Huang, Sajan Joseph, Michael Enrico Richett |
2008-11-11 |
$124,430,000 |
| 7414063 |
Inhibitors of Akt (protein kinase B) |
Rima Al-Awar, David Anthony Barda, Albert Gerard Dee, Kenneth J. Henry, Sajan Joseph +3 more |
2008-08-19 |
$128,982,000 |
| 7250430 |
Thiophene-and thiazolesulfonamides as antineoplastic agents |
Cora Sue Grossman, Philip Arthur Hipskind, Karen L. Lobb, Beatriz Lopez de Uralde Garmendia, Jose Eduardo Lopez +4 more |
2007-07-31 |
$79,905,000 |
| 7217727 |
Phospholipase inhibitors |
Patrick Irving Eacho, Patricia Sue Foxworthy-Mason, Jose Eduardo Lopez, Marian Mosior, Michael Enrico Richett |
2007-05-15 |
$90,905,000 |
| 7183320 |
Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
Chuan Shih, Cora Sue Grossman, Karen L. Lobb, Thomas H. Corbett, Philip Arthur Hipskind |
2007-02-27 |
$180,320,000 |
| 7084170 |
Thiophene-amd thiazolesulfonamides as antineoplastic agents |
Cora Sue Grossman, Philip Arthur Hipskind, Karen L. Lobb, Beatriz Lopez de Uralde Garmendia, Jose Eduardo Lopez +4 more |
2006-08-01 |
$113,149,000 |
| 6992100 |
sPLA2 inhibitors |
Douglas Wade Beight, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett, Daniel Jon Sall +2 more |
2006-01-31 |
$137,113,000 |
| 6974831 |
sPLA2 inhibitors |
Douglas Wade Beight, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett, Daniel Jon Sall +2 more |
2005-12-13 |
$297,119,000 |
| 6939890 |
sPLA2 inhibitors |
Richard Waltz Harper, Michael Enrico Richett |
2005-09-06 |
$160,407,000 |
| 6933313 |
Substituted carbazoles as inhibitors of sPLA2 |
Richard Waltz Harper, Michael Enrico Richett |
2005-08-23 |
$153,879,000 |
| 6930123 |
sPLA2 inhibitors |
Douglas Wade Beight, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett, Daniel Jon Sall +2 more |
2005-08-16 |
$149,308,000 |
| 6916840 |
Spla2 inhibitors |
Douglas Wade Beight, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett, Daniel Jon Sall +2 more |
2005-07-12 |
$161,399,000 |
| 6872743 |
sPLA2 inhibitors |
Douglas Wade Beight, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett, Daniel Jon Sall +1 more |
2005-03-29 |
$258,421,000 |
| 6831095 |
Hydroxyfunctional amide 1h-indole derivatives active as sPLA2 inhibitors |
Richard Waltz Harper, Michael Enrico Richett |
2004-12-14 |
$319,174,000 |
| 6743794 |
Methods and compounds for inhibiting MRP1 |
Rosanne Bonjouklian, Jeffrey Daniel Cohen, Joseph Michael Gruber, Douglas Webb Johnson, Louis Nickolaus Jungheim +14 more |
2004-06-01 |
$118,923,000 |
| 6713505 |
spla2 inhibitors |
Michael Dean Kinnick, Michael John Martinelli, John Michael Morin, Jr., Michael Enrico Richett |
2004-03-30 |
$108,187,000 |
| 6713645 |
Substituted tricyclics |
Nicholas J. Bach, Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer +17 more |
2004-03-30 |
$108,187,000 |
| 6706752 |
sPLA2 inhibitors |
Michael Enrico Richett |
2004-03-16 |
$422,846,000 |
| 6635670 |
sPLA2 inhibitors |
Michael Enrico Richett |
2003-10-21 |
$164,015,000 |
| 6541499 |
Antithrombotic agents |
Jolie Anne Bastian, Nickolay Y Chirgadze, Michael Lyle Denney, Matthew Joseph Fisher, Robert J. Foglesong +14 more |
2003-04-01 |
$118,606,000 |
| 6448422 |
Chromogenic compound |
Patrick Irving Eacho, Patricia Sue Foxworthy-Mason, Richard Waltz Harper, Jose Eduardo Lopez, Michael Enrico Richett |
2002-09-10 |
$109,326,000 |
| 6391901 |
Thrombin inhibitors |
Nickolay Y Chirgadze, Michael Lyle Denney, Matthew Joseph Fisher, Robert J. Foglesong, Richard Waltz Harper +10 more |
2002-05-21 |
$135,593,000 |
| 6391908 |
Oxime amide indole type sPLA2 inhibitors |
Nicholas J. Bach, Richard Waltz Harper, Michael Dean Kinnick, John Michael Morin, Jr., Michael Enrico Richett |
2002-05-21 |
$135,593,000 |
